Finally, we examined the association of FASN protein expression with metastasis in the combined JHU and PCBN cohorts, stratifying by BMI because high FASN was previously shown to be associated with lethal prostate cancer specifically for obese patients (8). Here, FASN is linked to prostate carcinoma.